Physicians, students, researchers and service providers converged this week on Chicago for the 2018 meeting of the American Association for Cancer Research. Overall attendance at the conference was nearly 17,000. Even bone-chilling wind and snow could dampen the enthusiasm for this much-anticipated event.
The AACR conference covers every aspect of cancer research and treatment, from basic information all the way to presentations about futuristic treatments currently being developed. World class scientists took to the podium and the jammed hallways to share their research and forge personal and professional alliances.
In this interview blog, Stephanie Langouet, Cmed’s Sr Vice President of CRO Operations, shares some of the challenges of drug development and research for rare diseases in children. She hopes that by sharing and properly collaborating we can all contribute to a better future for those who suffer from a rare disease.
What is a rare disease and why should they be studied? A rare disease is any disorder that affects a small percentage of the population.
The 9th Annual SCOPE Summit for Clinical Ops Executives conference was fun filled and productive. Held in Orlando, FL last week, the conference focused on innovative solutions in all aspects of clinical trial planning, management and operations.
We enjoyed speaking with many people who stopped at our booth wanting to find out more about how we combine our extensive experience in Data & Analytics with our encapsia® clinical data suite to set up and conduct trials smarter and more efficiently.